Search results
Is a Summer COVID Booster Worth It?
Verywell Health via Yahoo News· 3 days agoPeople who didn’t get a fall booster are eligible to get it now. Those who are 65+ were eligible to get a spring booster, too. COVID- ...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 2 days agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 1 day agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
FDA to vote Wednesday on COVID-19 shots to target emerging variants in US for 2024-25
Detroit News· 4 days agoAdvisory Committee, which evaluates and recommends vaccine formulas with the highest likelihood of...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 5 days agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 5 days agoThe company had said last month it would only be able to offer aCOVID vaccine in the United States...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 days agoThe vote comes as the U.S., like the rest of the world, is seeing a decline in the vaccination rate...
Harlingen receives updated COVID-19 boosters, to begin administrating Friday
KRGV Rio Grande Valley· 4 days agoThe Harlingen Health Department has received 300 doses of the updated Pfizer booster shot and will...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoKeep tabs on IBD Digital for more on stock ratings. What's AfterCovid Shots? Investors are closely...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 1 day ago"Recall that consumer hesitancy regarding Covid boosters has been driven in part by fears about...